Form 4 for CNSP CNS Pharmaceuticals, Inc.
Accepted 2022-03-09 00:00:00 ET · period of report 2022-03-07 · accession 0001683168-22-001546 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-03-09 | 2022-03-07 | CNSP | Keyes Jeffry R. | Dir | A - Grant | $0.3 | +11.1K | 11.1K | New | +$3,330 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-07 | A | A | 11,100 | $0.3 | 11,100 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $0.2685 to $2999. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |